Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1991 1
1998 1
2001 2
2002 1
2006 2
2007 1
2008 1
2009 1
2010 2
2011 4
2012 6
2013 3
2014 2
2015 7
2016 6
2017 6
2018 5
2019 3
2020 7
2021 8
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
Rosenberg AJ, Vokes EE. Rosenberg AJ, et al. Oncologist. 2021 Jan;26(1):40-48. doi: 10.1634/theoncologist.2020-0303. Epub 2020 Sep 21. Oncologist. 2021. PMID: 32864799 Free PMC article. Review.
Treatment of locoregionally advanced head and neck squamous cell carcinoma involves a multidisciplinary approach that combines surgery, radiotherapy, and systemic therapy. ...With the emergence of human papillomavirus (HPV) as an e …
Treatment of locoregionally advanced head and neck squamous cell carcinoma involves a multidiscipl …
Adjuvant treatment for post-operative head and neck squamous cell carcinoma.
Kiyota N, Tahara M, Fujii M. Kiyota N, et al. Jpn J Clin Oncol. 2015 Jan;45(1):2-6. doi: 10.1093/jjco/hyu195. Epub 2014 Nov 19. Jpn J Clin Oncol. 2015. PMID: 25411434 Review.
One of the mainstays of treatment for locally advanced head and neck squamous cell carcinoma is surgery. However, for post-operative patients with high-risk factors for recurrence, surgery alone is insufficient and improving survival requ …
One of the mainstays of treatment for locally advanced head and neck squamous cell carcinoma is su …
EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.
Sundvall M, Karrila A, Nordberg J, Grénman R, Elenius K. Sundvall M, et al. Expert Opin Emerg Drugs. 2010 Jun;15(2):185-201. doi: 10.1517/14728211003716442. Expert Opin Emerg Drugs. 2010. PMID: 20415599 Review.
IMPORTANCE OF THE FIELD: Head and neck cancer is the sixth most common cancer worldwide. Despite intense efforts to improve different treatment modalities, mortality rates in advanced cases remain high. AREAS COVERED IN THE REVIEW: EGFR targeting mAb cetuxima …
IMPORTANCE OF THE FIELD: Head and neck cancer is the sixth most common cancer worldwide. Despite intense efforts to improve di …
Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: the 'RADPLAT' protocol.
Kumar P, Robbins KT. Kumar P, et al. Curr Oncol Rep. 2001 Jan;3(1):59-65. doi: 10.1007/s11912-001-0044-1. Curr Oncol Rep. 2001. PMID: 11123871 Review.
The prognosis for patients presenting with advanced head and neck squamous cell carcinoma using "standard" treatment approaches, such as surgery followed by radiotherapy or radiotherapy alone, remains poor. ...This article reviews the evo …
The prognosis for patients presenting with advanced head and neck squamous cell carcinoma using "s …
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Cavalieri S, Platini F, Barretta F, Nuzzolese I, Ottini A, Bergamini C, Resteghini C, Colombo E, Iacovelli NA, Franceschini M, Calareso G, Di Pede P, De Feo G, Gandelli M, Toffolatti L, Guglielmo M, Ripamonti CI, Cosmai L, Licitra L, Alfieri S. Cavalieri S, et al. Oral Oncol. 2023 Nov;146:106579. doi: 10.1016/j.oraloncology.2023.106579. Epub 2023 Sep 29. Oral Oncol. 2023. PMID: 37778228
OBJECTIVES: Cisplatin is essential in the curative treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC) patients. ...
OBJECTIVES: Cisplatin is essential in the curative treatment of locally advanced head and neck squamous cell
Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience.
Karivedu V, Bonomi M, Issa M, Blakaj A, Klamer BG, Pan X, Old M, Bhateja P, Kang S, Seim N, Ozer E, Agrawal A, Mitchell D, Gamez ME, Grecula J, Jhawar SR, Baliga S, Carrau RL, Rocco J, Blakaj D. Karivedu V, et al. Oncol Res Treat. 2021;44(10):521-529. doi: 10.1159/000518548. Epub 2021 Aug 17. Oncol Res Treat. 2021. PMID: 34515190 Free article.
OBJECTIVES: This study aimed to assess the effect of definitive or adjuvant concurrent chemoradiation (CRT) among elderly patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC). MATERIALS AND METHODS: We retrospec …
OBJECTIVES: This study aimed to assess the effect of definitive or adjuvant concurrent chemoradiation (CRT) among elderly patients with loca …
Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01).
Kang EJ, Lee YG, Keam B, Choi JH, Kim JS, Park KU, Lee KE, Kim HJ, Lee KW, Kim MK, Ahn HK, Shin SH, Lee JB, Kwon JH, Kim HR, Kim SB, Yun HJ. Kang EJ, et al. Korean J Intern Med. 2022 Jan;37(1):190-200. doi: 10.3904/kjim.2020.636. Epub 2021 Dec 21. Korean J Intern Med. 2022. PMID: 34929077 Free PMC article.
BACKGROUND/AIMS: Treatment decisions for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) are complicated, and multi-modal treatments are usually indicated. ...Proportions of primary tumors in the hypopharynx and larynx w …
BACKGROUND/AIMS: Treatment decisions for locally advanced head and neck squamous cell carcinoma (L …
Elderly Patients with Advanced Head and Neck Carcinoma: Does Aggressive Treatment Result in Better Outcomes?
Jang IJH, Skanthakumar T, Tan HK, Tan NC, Soo KC, Iyer NG. Jang IJH, et al. Otolaryngol Head Neck Surg. 2019 Apr;160(4):642-650. doi: 10.1177/0194599818815065. Epub 2018 Dec 18. Otolaryngol Head Neck Surg. 2019. PMID: 30558490
OBJECTIVE: There are no well-defined treatment recommendations for elderly patients with advanced head and neck squamous cell carcinoma. This study aimed to investigate whether aggressive treatment among the elderly translated into better …
OBJECTIVE: There are no well-defined treatment recommendations for elderly patients with advanced head and neck squa
AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
Fulcher CD, Haigentz M Jr, Ow TJ; Education Committee of the American Head and Neck Society (AHNS). Fulcher CD, et al. Head Neck. 2018 Apr;40(4):676-686. doi: 10.1002/hed.25025. Epub 2017 Nov 24. Head Neck. 2018. PMID: 29171929 Free PMC article. Review.
This article is a continuation of the "Do You Know Your Guidelines" series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma
This article is a continuation of the "Do You Know Your Guidelines" series, initiated by the Education committee of the American Head
The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment.
Maggiore R, Zumsteg ZS, BrintzenhofeSzoc K, Trevino KM, Gajra A, Korc-Grodzicki B, Epstein JB, Bond SM, Parker I, Kish JA, Murphy BA, VanderWalde NA; CARG-HNC Study Group. Maggiore R, et al. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):868-883. doi: 10.1016/j.ijrobp.2017.02.022. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602414 Free PMC article. Review.
Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care providers. ...The findings highlight the importance of a geriatric assessment …
Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive c
63 results